APA (7th ed.) Citation

AC, O., G, M., B, S., S, M., P, A., N, P., & K, U. (2025). Clinical Exploration and Physiologically Based Modelling of the Impact of Hepatic Impairment on Entrectinib Pharmacokinetics. Clinical pharmacokinetics, 64(3), 437. https://doi.org/10.1007/s40262-024-01468-y

Chicago Style (17th ed.) Citation

AC, Ozbey, Meneses-Lorente G, Simmons B, McCallum S, Annaert P, Parrott N, and Umehara K. "Clinical Exploration and Physiologically Based Modelling of the Impact of Hepatic Impairment on Entrectinib Pharmacokinetics." Clinical Pharmacokinetics 64, no. 3 (2025): 437. https://doi.org/10.1007/s40262-024-01468-y.

MLA (9th ed.) Citation

AC, Ozbey, et al. "Clinical Exploration and Physiologically Based Modelling of the Impact of Hepatic Impairment on Entrectinib Pharmacokinetics." Clinical Pharmacokinetics, vol. 64, no. 3, 2025, p. 437, https://doi.org/10.1007/s40262-024-01468-y.